Allianz Asset Management GmbH Boosts Stake in National Health Investors, Inc. $NHI

Allianz Asset Management GmbH increased its stake in shares of National Health Investors, Inc. (NYSE:NHIFree Report) by 111.9% in the second quarter, HoldingsChannel.com reports. The firm owned 120,625 shares of the real estate investment trust’s stock after buying an additional 63,697 shares during the period. Allianz Asset Management GmbH’s holdings in National Health Investors were worth $8,458,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in NHI. Smartleaf Asset Management LLC boosted its position in shares of National Health Investors by 49.8% during the 1st quarter. Smartleaf Asset Management LLC now owns 442 shares of the real estate investment trust’s stock worth $33,000 after purchasing an additional 147 shares during the period. NewEdge Advisors LLC boosted its position in shares of National Health Investors by 28.7% during the 1st quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock worth $114,000 after purchasing an additional 345 shares during the period. Jupiter Asset Management Ltd. purchased a new position in shares of National Health Investors during the 1st quarter worth approximately $206,000. Xponance Inc. boosted its position in shares of National Health Investors by 11.2% during the 1st quarter. Xponance Inc. now owns 3,334 shares of the real estate investment trust’s stock worth $246,000 after purchasing an additional 337 shares during the period. Finally, Monument Capital Management purchased a new position in shares of National Health Investors during the 2nd quarter worth approximately $252,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on NHI shares. Truist Financial increased their price objective on shares of National Health Investors from $77.00 to $81.00 and gave the stock a “buy” rating in a research report on Friday, August 15th. Cantor Fitzgerald initiated coverage on shares of National Health Investors in a research report on Wednesday, October 1st. They issued an “overweight” rating and a $90.00 price target for the company. National Bankshares set a $90.00 price target on shares of National Health Investors in a research report on Wednesday, October 1st. Wells Fargo & Company raised their price target on shares of National Health Investors from $76.00 to $80.00 and gave the company an “equal weight” rating in a research report on Wednesday, August 27th. Finally, Weiss Ratings reissued a “buy (b-)” rating on shares of National Health Investors in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $84.83.

View Our Latest Stock Report on NHI

National Health Investors Price Performance

National Health Investors stock opened at $74.77 on Wednesday. The stock has a market cap of $3.55 billion, a P/E ratio of 23.89, a price-to-earnings-growth ratio of 3.44 and a beta of 0.77. The company has a fifty day simple moving average of $77.07 and a 200-day simple moving average of $74.13. National Health Investors, Inc. has a 12-month low of $65.13 and a 12-month high of $82.32. The company has a current ratio of 10.91, a quick ratio of 10.91 and a debt-to-equity ratio of 0.75.

National Health Investors (NYSE:NHIGet Free Report) last released its quarterly earnings data on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.16 by $0.06. The business had revenue of $70.27 million during the quarter, compared to analysts’ expectations of $86.46 million. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the previous year, the company earned $1.18 EPS. Equities analysts expect that National Health Investors, Inc. will post 4.41 EPS for the current fiscal year.

National Health Investors Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be given a dividend of $0.92 per share. This is an increase from National Health Investors’s previous quarterly dividend of $0.90. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $3.68 annualized dividend and a dividend yield of 4.9%. National Health Investors’s dividend payout ratio is presently 117.57%.

National Health Investors Company Profile

(Free Report)

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Further Reading

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHIFree Report).

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.